Analgesic Effect of Adding an Adductor Canal Block to a Femoral Triangle Block for Total Knee Replacement

October 6, 2020 updated by: Changi General Hospital

A Randomised Controlled Trial Investigating the Addition of an Adductor Canal Block to a Femoral Triangle Block for Analgesia After Total Knee Replacement

The aim of the study is to investigate whether the addition of an adductor canal block to a femoral triangle block will provide better analgesia for patients after total knee replacements.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Singapore
      • Singapore, Singapore, 529889
        • Changi General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing total knee arthroplasty under spinal anaesthesia
  • 45y or older
  • ASA 1-3
  • BMI 18-35

Exclusion Criteria:

  • Unable to consent
  • Chronic opioid consumption
  • Allergy to study medication
  • Lower limb surgery preceding year
  • Unable to complete baseline testing, pre-existing neurological deficit
  • Contraindication to spinal anaesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Adductor canal block Femoral triangle block
Procedure: Adductor canal block
Single shot block with 0.5% bupivacaine 10mls
Procedure: Femoral triangle block
Single shot block with 0.5% bupivacaine 10mls
Active Comparator: Standard
Femoral triangle block
Procedure: Femoral triangle block
Single shot block with 0.5% bupivacaine 10mls

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid consumption
Time Frame: 24 hours
Morphine
24 hours
Opioid consumption
Time Frame: 48 hours
Morphine
48 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle strength
Time Frame: 24 hours
measured with dynanometer
24 hours
Muscle strength
Time Frame: 48 hours
measured with dynanometer
48 hours
Time to up and go test
Time Frame: 24 hours
Time to get up from chair, walk 3 meters and return to chair
24 hours
Time to up and go test
Time Frame: 48 hours
Time to get up from chair, walk 3 meters and return to chair
48 hours
30 Chair stand test
Time Frame: 24 hours
Number of times a patient can stand up from sitting position in 30 seconds
24 hours
30 Chair stand test
Time Frame: 48 hours
Number of times a patient can stand up from sitting position in 30 seconds
48 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Changi General Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 22, 2018

Primary Completion (Actual)

March 31, 2020

Study Completion (Actual)

March 31, 2020

Study Registration Dates

First Submitted

February 25, 2018

First Submitted That Met QC Criteria

March 5, 2018

First Posted (Actual)

March 12, 2018

Study Record Updates

Last Update Posted (Actual)

October 8, 2020

Last Update Submitted That Met QC Criteria

October 6, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2017/ 2809 CGH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Replacements

Clinical Trials on Adductor canal block

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe